ENSURE PLUS FIBER MALINOVÁ PŘÍCHUŤ

Základní informace

  • Název přípravku:
  • ENSURE PLUS FIBER MALINOVÁ PŘÍCHUŤ Perorální roztok
  • Léková forma:
  • Perorální roztok
  • Podání:
  • Perorální podání
  • Jednotky v balení:
  • 1X200ML
  • Použij pro:
  • Lidé
  • Léčitelství typu:
  • alopatický drog

Dokumenty

Lokalizace

  • K dispozici v:
  • ENSURE PLUS FIBER MALINOVÁ PŘÍCHUŤ Perorální roztok
    Česká republika
  • Jazyk:
  • čeština

Terapeutická informace

  • Terapeutické oblasti:
  • POTRAVINY PRO ZVLÁŠTNÍ LÉKAŘSKÉ ÚČELY (PZLÚ)
  • Přehled produktů:
  • ENSURE PLUS FIBER MALINOVÁ PŘÍCHUŤ

Další informace

Stav

  • Zdroj:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Poslední aktualizace:
  • 22-06-2017

Příbalovou informaci pro pacienta


Potravina pro zvláštní lékařské účely/ Dietetická potravina na osobitné medicínske účely
ENSURE PLUS FIBER
Malinová příchuť/ Malinová príchuť
e 200 ml / 1,5kcal/ml / 310 kcal/200 ml 13 g bílkovin/200 ml / 13 g bielkovín/200 ml
Určeno k přímé spotřebě/ Určený na priame použitie Minimální trvanlivost do konce/ Minimálna trvanlivosť do konca: Baleno v ochranné atmosféře./ Balené v ochrannej atmosfére. Bez lepku/ Bezgluténový.
Vyrobeno v EU/ Vyrobené v EÚ Distr.: CZ - Abbott Laboratories, s.r.o., Hadovka Office Park, Evropská 2591/33d, 160 00 Praha 6, Česká republika. SK - Abbott Laboratories Slovakia s.r.o., Karadžičova 10, 821 08 Bratislava 2, Slovenská republika.

Nutriční informace/ Nutričné informácie

Jednotka

Ve 100 ml/ V 100 ml

Energetická hodnota

kJ/kcal

652/155

Tuky

g

4,92

Nasycené mastné kyseliny/ Nasýtené mastné kyseliny

g

0,42

Sacharidy

g

20,20

Cukry

g

4,9

Vláknina

g

2,50

FOS*

g

1,25

Bílkoviny/ Bielkoviny

g

6,25

Sůl/ Soľ

g

0,21

Vit. A

mcg RE

117

Beta-karoten/ Betakarotén

mcg RE

29

Vit. D3

mcg

1,7

Vit. E

mg αTE

2,4

Vit. K1

mcg

12

Vit. C

mg

12

Kyselina listová

mcg

33

Vit. B1

mg

0,20

Vit. B2

mg

0,27

Vit. B6

mg

0,27

Vit. B12

mcg

0,65

Niacin/ Niacín

mg NE

2,6

Kyselina pantothenová/ Kyselina pantoténová

mg

1,1

Biotin/ Biotín

mcg

6,0

Sodík

mg

85

Draslík

mg

135

Chlór

mg

110

Vápník/ Vápnik

mg

70

Fosfor

mg

69

Hořčík/ Horčík

mg

30

Železo

mg

2,1

Zinek/ Zinok

mg

1,6

Mangan/ Mangán

mg

0,50

Měď/ Meď

mcg

180

Jód

mcg

22

Selen/ Selén

mcg

8,3

Chrom/ Chróm

mcg

7,5

Molybden/ Molybdén

mcg

16

Cholin/ Cholín

mg

55

Osmolarita: 552 mOsm/l *Fruktooligosacharid

Určeno k dietnímu postupu u pacientů s podvýživou nebo s rizikem vzniku podvýživy. Ensure Plus Fiber je vysoce energetická, kompletní a vyvážená výživa obsahující směs vlákniny a FOS* pro perorální použití. Návod k použití: Před otevřením dobře protřepejte. Po otevření výrobek uzavřete, uchovávejte v chladničce a spotřebujte do 24 hodin. Neotevřenou výživu uchovávejte při pokojové teplotě. Důležité upozornění: Tento produkt je výživový doplněk. Používejte na základě doporučení lékaře nebo osoby kvalifikované v oblasti výživy lidí, farmacie nebo péče o matku a dítě. Sledujte příjem tekutin pro zajištění náležitého stavu hydratace. Není určeno pro děti, pokud to nedoporučí lékař nebo osoba kvalifikovaná v oblasti výživy. Neužívat při galaktosémii. Nepodávat parenterálně.
Složení: voda, hydrolyzovaný kukuřičný škrob, mléčné bílkoviny, rostlinné oleje (řepkový olej, slunečnicový olej s vysokým obsahem kyseliny olejové, kukuřičný olej), sacharóza, FOS*, izolovaná sójová bílkovina, sójový polysacharid, minerály (citronan draselný, chlorid hořečnatý, tribázický fosforečnan vápenatý, síran železnatý, síran zinečnatý, síran manganatý, síran měďnatý, molybdenan sodný, jodid draselný, chlorid chromitý, selenan sodný), ovesná vláknina, arabská guma, aroma, emulgátor: sójový lecitin, karboxymetylcelulóza, cholin chlorid, vitamíny (C, E, nikotinamid, pantothenan vápenatý, B6, B1, B2, beta-karoten, vit. A palmitát, kyselina listová, K1, biotin, D3, B12), barvivo: E120, stabilizátor: E418.
Pre diétny režim pacientov s podvýživou alebo s rizikom vzniku podvýživy. Ensure Plus Fiber je vysokoenergetická, kompletná a vyrovnaná výživa so zmesou vlákniny a FOS* na perorálne užívanie. Návod na použitie: Pred otvorením dobre pretrepte. Po otvorení výrobok uzavrite, uchovávajte v chladničke a spotrebujte do 24 hodín. Neotvorený produkt uchovávajte pri izbovej teplote. Dôležité upozornenie: Tento produkt je vhodný ako jediný alebo doplnkový zdroj výživy. Môže sa používať len pod lekárskym dohľadom. Monitorujte príjem tekutín, aby ste zabezpečili primeranú hydratáciu. Nie je určený pre deti, pokiaľ ho neodporučí lekár alebo zdravotnícky pracovník kvalifikovaný v oblasti klinickej výživy. Nepoužívať pri galaktosémii. Nepodávať parenterálne.
Zloženie: voda, hydrolyzovaný kukuričný škrob, mliečne bielkoviny, rastlinné oleje (repkový olej, slnečnicový olej s vysokým obsahom kyseliny olejovej, kukuričný olej), sacharóza, FOS*, izolovaná sójová bielkovina, sójový polysacharid, minerály (káliumcitrát, chlorid horečnatý, tribázický fosforečnan vápenatý, síran železnatý, síran zinočnatý, síran manganatý, síran meďnatý, molybdénan sodný, jodid draselný, chlorid chromitý, selénan sodný), ovsená vláknina, arabská guma, aróma, emulgátor: sójový lecitín, karboxymetylcelulóza, cholíniumchlorid, vitamíny (C, E, nikotínamid, kalciumpantotenát, B6, B1, B2, betakarotén, vitamín A (retinylpalmitát), kyselina listová, K1, biotín, D3, B12), farbivo: E120, stabilizátor: E418.

160-538-000 M701 ©2014Abbott

25-9-2018

Daiso Holdings Ltd. recalls Daiso Brand Consumer Chemical Products

Daiso Holdings Ltd. recalls Daiso Brand Consumer Chemical Products

The recalled products have not been properly classified according to the Consumer Chemicals and Containers Regulations, 2001, in order to ensure appropriate hazard labelling. These regulations are empowered by the Canada Consumer Product Safety Act. Improper labelling could result in unintentional exposure to these products and lead to serious illness, injury or death.

Health Canada

11-9-2018

Assessment of occupational and dietary exposure to pesticide residues

Assessment of occupational and dietary exposure to pesticide residues

Published on: Mon, 27 Aug 2018 00:00:00 +0200 Plant protection products (PPPs) are pesticides containing at least one active substance that drives specific actions against pests (diseases). PPPs are regulated in the EU and cannot be placed on the market or used without prior authorisation. EFSA assesses the possible risks of the use of active substances to humans and environment. Member States decide whether or not to approve their use at EU level. Furthermore, Member States decide at national level on ...

Europe - EFSA - European Food Safety Authority Publications

7-9-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to help ensure the quality of and preserve access to compounded drugs by pursuing closer collaboration with states

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to help ensure the quality of and preserve access to compounded drugs by pursuing closer collaboration with states

FDA announces revised draft memorandum of understanding between FDA and the states to help ensure the quality of and preserve access to compounded drugs

FDA - U.S. Food and Drug Administration

5-9-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s global efforts to help assure product quality and transparency at foreign drug manufacturing facilities

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s global efforts to help assure product quality and transparency at foreign drug manufacturing facilities

FDA is publishing its internal policy for how manufacturing facilities are prioritized and scheduled for surveillance inspections in an effort to ensure the quality and safety of globally produced products.

FDA - U.S. Food and Drug Administration

30-8-2018

Grant agreement for piloting the Framework Partnership Agreement between the National data provider organisations in Cyprus and EFSA – Final report

Grant agreement for piloting the Framework Partnership Agreement between the National data provider organisations in Cyprus and EFSA – Final report

Published on: Tue, 07 Aug 2018 00:00:00 +0200 Cyprus alongside with another 4 countries has participated successfully in the Grant Agreement GP/EFSA/DATA/2016/01‐GA 02, entitled: “Strategic Partnership with Cyprus on Data Quality”. The project was co‐financed by EFSA, aiming to help both EFSA and data providers from Member States to possess data of high quality in a quantitatively manageable way. The main objective of the grant agreement was the establishment of the data governance, coordination and imp...

Europe - EFSA - European Food Safety Authority Publications

30-8-2018

Grant agreement for piloting the Framework Partnership Agreement between the National data provider organisations in Denmark and EFSA – Final report

Grant agreement for piloting the Framework Partnership Agreement between the National data provider organisations in Denmark and EFSA – Final report

Published on: Tue, 07 Aug 2018 00:00:00 +0200 During the project seven standard operating procedures (SOP) were developed for the four data domains (zoonoses, chemical contaminant, pesticide residues and veterinary medical products residues). The SOPs describe 1) How the national governance of risk assessment data is organised, 2) how data are collected and validated before delivering to EFSA covering all four domains, 3) How data is transferred to EFSA, 4) how to respond to EFSA request for clarificati...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Safety assessment of the process ‘General Plastic’, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials

Safety assessment of the process ‘General Plastic’, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials

Published on: Fri, 10 Aug 2018 00:00:00 +0200 This scientific opinion of the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF Panel) deals with the safety evaluation of the recycling process General Plastic (EU register No RECYC153), which is based on the Starlinger Decon technology. The decontamination efficiency of the process was demonstrated by a challenge test. The input of this process is hot caustic washed and dried poly(ethylene terephthalate) (PET) flakes orig...

Europe - EFSA - European Food Safety Authority Publications

17-7-2018

ALDI Voluntarily Recalls AnnaSea Wasabi Ahi Poke Hawaiian Poke Kits and Limu Ahi Poke Hawaiian Poke Kits Due to Storage at Incorrect Temperature in Area Store

ALDI Voluntarily Recalls AnnaSea Wasabi Ahi Poke Hawaiian Poke Kits and Limu Ahi Poke Hawaiian Poke Kits Due to Storage at Incorrect Temperature in Area Store

Batavia, Ill. Uuly 14, 2018) -ALDI has voluntarily recalled AnnaSea Wasabi Ahi Poke Hawaiian Poke Kits and Limu Ahi Poke Hawaiian Poke Kits sold at one retail store location in North Carolina. While the products are required to remain at frozen temperatures to ensure safety, this store location displayed and sold the products from the cooler section. Because storing the products at temperatures above freezing prior to consumption can render the products unsafe for consumption, ALDI is recalling these items.

FDA - U.S. Food and Drug Administration

14-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to better equip consumers with nutritional information about dietary fiber in their food

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to better equip consumers with nutritional information about dietary fiber in their food

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to better equip consumers with nutritional information about dietary fiber in their food

FDA - U.S. Food and Drug Administration

22-5-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens

Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens

The FDA is announcing three new efforts as part of a comprehensive set of actions to advance the FDA’s framework for sun protection products ahead of this coming summer

FDA - U.S. Food and Drug Administration

15-5-2018

Nonprescription Drugs Advisory Committee

Nonprescription Drugs Advisory Committee

he Nonprescription Drugs Advisory Committee advises the Commissioner or designee in discharging responsibilities as they relate to helping to ensure safe and effective drugs for human use and, as required, any other product for which the Food and Drug Administration has regulatory responsibility.

FDA - U.S. Food and Drug Administration

2-6-2017

Additional Risk Minimisation Measures (aRMM)

Additional Risk Minimisation Measures (aRMM)

From 1 June 2017 IMA will take seven days to ensure that all relevant documents are enclosed in an application for aRMM evaluation. This is done to facilitate IMAs review of the material.

IMA - Icelandic Medicines Agency

18-12-2006

Reassessment of reimbursement status

Reassessment of reimbursement status

This summer, the Danish Medicines Agency will begin the periodic reassessment of reimbursement status of medicinal products. Over a 5-year period, the reimbursement status of all medicinal products will be reassessed to ensure that the medicinal products having been granted general reimbursement still meet the required criteria and that medicinal products which have not been granted general reimbursement do not meet the criteria.

Danish Medicines Agency

24-9-2018

News and press releases:  Companies stepping up efforts to ensure medicine supply post Brexit

News and press releases: Companies stepping up efforts to ensure medicine supply post Brexit

Focus is now on 39 centrally authorised medicines, down from 108

Europe - EMA - European Medicines Agency

22-8-2018

Routine eye exams and visiting your eye doctor will help ensure and maintain healthy eyes for everyone. #OnePairTakeCare #FDA #MedicalDevicepic.twitter.com/SQYFz30oFy

Routine eye exams and visiting your eye doctor will help ensure and maintain healthy eyes for everyone. #OnePairTakeCare #FDA #MedicalDevicepic.twitter.com/SQYFz30oFy

Routine eye exams and visiting your eye doctor will help ensure and maintain healthy eyes for everyone. #OnePairTakeCare #FDA #MedicalDevice pic.twitter.com/SQYFz30oFy

FDA - U.S. Food and Drug Administration

21-8-2018

It’s Contact Lens Health Week and the FDA is working to ensure safe and useful devices are available to patients and consumers. Check out our recent contact lens approvals:  https://go.usa.gov/xUz4M  and https://go.usa.gov/xUz4t  #OnePairTakeCarepic.twitt

It’s Contact Lens Health Week and the FDA is working to ensure safe and useful devices are available to patients and consumers. Check out our recent contact lens approvals: https://go.usa.gov/xUz4M  and https://go.usa.gov/xUz4t  #OnePairTakeCarepic.twitt

It’s Contact Lens Health Week and the FDA is working to ensure safe and useful devices are available to patients and consumers. Check out our recent contact lens approvals: https://go.usa.gov/xUz4M  and https://go.usa.gov/xUz4t  #OnePairTakeCare pic.twitter.com/PcxUGHgwoV

FDA - U.S. Food and Drug Administration

20-8-2018

Contact Lens Health Week is here and the FDA and @CDCgov are reminding you of safe measures to ensure proper use of contact lenses. Check out the CDC’s Healthy Habits Mean Healthy Eye video #OnePairTakeCarepic.twitter.com/jxiBHA3CiT

Contact Lens Health Week is here and the FDA and @CDCgov are reminding you of safe measures to ensure proper use of contact lenses. Check out the CDC’s Healthy Habits Mean Healthy Eye video #OnePairTakeCarepic.twitter.com/jxiBHA3CiT

Contact Lens Health Week is here and the FDA and @CDCgov are reminding you of safe measures to ensure proper use of contact lenses. Check out the CDC’s Healthy Habits Mean Healthy Eye video #OnePairTakeCare pic.twitter.com/jxiBHA3CiT

FDA - U.S. Food and Drug Administration

27-7-2018

Scientific guideline:  Reflection paper on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics (SPC) harmonisation, draft: consultation open

Scientific guideline: Reflection paper on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics (SPC) harmonisation, draft: consultation open

Established veterinary antibiotics are not always used at the authorised dose, and the dose may need to be reviewed in order to maintain their effectiveness whilst limiting the risks of antimicrobial resistance. Before a new dose is introduced, the company would typically have to conduct new studies to ensure it does not negatively affect the safety of the target animal, the consumer of animal produce, or the environment. This may reduce product availability, which could have a negative impact on antimic...

Europe - EMA - European Medicines Agency

22-7-2018

Our aim: ensure that devices not only meet the gold standard for getting to market but continue to meet this standard as we get more data and learn more about their benefit-risk profile in real-world settings. These new approaches will also help advance b

Our aim: ensure that devices not only meet the gold standard for getting to market but continue to meet this standard as we get more data and learn more about their benefit-risk profile in real-world settings. These new approaches will also help advance b

Our aim: ensure that devices not only meet the gold standard for getting to market but continue to meet this standard as we get more data and learn more about their benefit-risk profile in real-world settings. These new approaches will also help advance beneficial innovation

FDA - U.S. Food and Drug Administration

18-7-2018

HSCC announced today a new workstream, conducted under the Task Group, that will discuss and seek input on a software bill of materials (SBOM) for medical devices. SBOMs can ensure that users have better understanding of what software elements are in a me

HSCC announced today a new workstream, conducted under the Task Group, that will discuss and seek input on a software bill of materials (SBOM) for medical devices. SBOMs can ensure that users have better understanding of what software elements are in a me

HSCC announced today a new workstream, conducted under the Task Group, that will discuss and seek input on a software bill of materials (SBOM) for medical devices. SBOMs can ensure that users have better understanding of what software elements are in a medical device.

FDA - U.S. Food and Drug Administration

29-5-2018

Ensure that you have optimised your Class I medical device ARTG entries

Ensure that you have optimised your Class I medical device ARTG entries

Information sheet to assist sponsors to optimise their Class I ARTG

Therapeutic Goods Administration - Australia

22-5-2018

Statement from @SGottliebFDA on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens:  http://go.usa.gov/xQmjP 

Statement from @SGottliebFDA on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens: http://go.usa.gov/xQmjP 

Statement from @SGottliebFDA on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens: http://go.usa.gov/xQmjP 

FDA - U.S. Food and Drug Administration